Scottish Medicines Consortium accepts upadacitinib to treat Active Ulcerative Colitis in Adults
The Scottish Medicines Consortium (SMC) has accepted AbbVie‘s RINVOQ (upadacitinib) for use within NHS Scotland for the treatment of adult patients with moderately to...